Shrivastava, T., Muttineni, S., Dronavalli, S., Cheema, H. I., Krain, S., Buck, A. M., Schinke, C. D., Trikannad, A. K., Shrestha, A., Naqvi, S., Thanendrarajan, S., Rhee, F. V., Coleman, L., Zangari, M. (2026). Real-world infectious complications and IVIG utilization after teclistamab in relapsed/refractory multiple myeloma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e19516